Mico BioMed Obtains Export Approval for COVID-19 Kits Following Diagnostic Equipment... Expanding Global Exports

Orders for PCR Molecular Diagnostic Equipment and Diagnostic Kits from Europe and South America

[Asia Economy Reporter Hyungsoo Park] Miko's subsidiary, MikobioMed, has received export approval from the Ministry of Food and Drug Safety for molecular diagnostic kits for COVID-19 testing, expanding the supply of export volumes worldwide.

MikobioMed announced on the 27th that it received export approval from the Ministry of Food and Drug Safety for COVID-19 diagnostic kits used in PCR molecular diagnostic equipment.

While the PCR molecular diagnostic equipment had already received export approval as medical devices, the diagnostic kits have now also received additional export approval. MikobioMed, which is exporting to Bangladesh and Senegal, is also receiving orders for diagnostic kits from Europe and South America. In Europe, orders for PCR equipment and diagnostic reagents have been received from Poland, Hungary, and Romania. In South America, orders for PCR equipment and diagnostic reagents have been received from Ecuador and Brazil.

In Brazil, 10 sets of MikobioMed's PCR equipment have been installed in mobile vehicles to operate testing labs as Mobile Labs. It is known that an order for 50,000 test reagents has been placed. This was made possible through MikobioMed's proposal, and discussions are ongoing to supply additional quantities to testing sites besides the mobile vehicles, with the supply volume expected to gradually increase.

In the past, domestically, the Korea Disease Control and Prevention Agency equipped mobile vehicles with MikobioMed's equipment to operate as anti-terrorism diagnostic equipment at international sporting events such as the Pyeongchang Olympics and the Gwangju World Swimming Championships.

A company official said, "Based on the successful clinical results from the Pasteur Institute and the advantages of our PCR equipment's rapid diagnostic speed and miniaturization enabling on-site diagnosis, orders are coming from countries around the world," adding, "We obtained CE certification on the 7th and have applied for Emergency Use Authorization from the U.S. FDA and are awaiting the results."

He emphasized, "We will actively promote advanced PCR equipment and diagnostic reagents worldwide and aggressively target the global market."

This content was produced with the assistance of AI translation services.